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Abstract
Background: The eradication of facultative intracellular bacterial pathogens, like Salmonella typhi, requires the concerted
action of both the humoral immune response and the cytotoxic CD8
+ T cell response. Dendritic cells (DCs) are considered to
orchestrate the cytotoxic CD8
+ T cell response via cross-presentation of bacterial antigens onto MHC class I molecules.
Cross-presentation of Salmonella by DCs however, is accompanied by the induction of apoptosis in the DCs. Besides
antibody production, B cells are required to clear Salmonella infection for other unknown reasons.
Methodology/Principal Findings: Here we show that Salmonella-specific B cells that phagocytose Salmonella upon BCR-
ligation reactivate human memory CD8
+ T cells via cross-presentation yielding a Salmonella-specific cytotoxic T cell
response. The reactivation of CD8
+ T cells is dependent on CD4
+ T cell help. Unlike the DCs, B cell-mediated cross-
presentation of Salmonella does not coincide with apoptosis.
Conclusions/Significance: B cells form a new player in the activation of the cytotoxic effector arm of the immune response
and the generation of effective adaptive immunity in Salmonella infection.
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Introduction
Salmonella is a pathogenic bacterium that causes severe disease in
mice and man. Salmonellatyphi(Salmonellaenterica serovar Typhi) causes
invasivediseases in human, whichhas many features in common with
Salmonella typhimurium in mice. The gastrointestinal tract is the major
site of primary infection of the host and has to be passed before
systemic infection can occur. One way to infect the host cells is via
sampling of bacteria by DCs in the intestine. In vitro studies showed
that DCs located in the lamina propria under the gut epithelium of
the small bowel extend processes across the tight junctions between
the epithelial cells and capture bacteria from the luminal side of the
gut [1,2]. The major route of infection however, is via microfold cells
or M cells[3,4]. The specialized antigen-sampling M cells are located
in the dome region of the Peyer’s Patches and are efficient in
transportation of macromolecules and microorganisms to the
underlying immune cells [2,5]. Like other Gram-negative bacteria,
Salmonella uses specific virulence factors to invade other cell types,
called the Type III Secretion System (TTSS). Many Salmonella
virulence genes are clustered in Salmonellapathogenicity islands (SPIs).
SPI-1 and SPI-2 encode TTSSs that mediate the injection of effector
proteins into the host cell cytoplasm via sophisticated secretion
devices [6]. SPI-1is associated withinvasionof intestinal epitheliaand
enhanced intestinal inflammation in the infected host [7,8]. SPI-2
modulates intracellular trafficking and enables replication within a
modified vacuolar compartment, called the Salmonella-containing
vacuole (SCV) [9–11] and enhances inflammation during enteric
phase [12,13]. Salmonella activates the PKB/Akt1 pathway to prevent
maturation of SCV into destructive phagolysosomes, thus manipu-
lating the host for its own survival [14].
After transcytosis by M cells, Salmonella reaches the subepithelial
dome of the Peyer’s patches and encounters an extensive network
of resident macrophages, DCs and great numbers of B cells
[15,16]. Instead of being immediately destroyed by these cells,
Salmonella have evolved several mechanisms to survive in the harsh
milieu of phagosomal compartments [17] and can be cytotoxic to
macrophages by inducing apoptosis in vitro [18,19].
Recently, we showed that recognition of Salmonella via the
specific B cell receptor (BCR) on B cells results in internalization of
Salmonella. Salmonella is able to survive intracellularly in primary B
cells in a non-replicative state [20]. Following uptake of Salmonella,
B cells do not go into apoptosis, but differentiate and start to
produce Salmonella-specific antibodies. In addition, BCR-mediated
phagocytosis of Salmonella by B cells leads to antigen presentation
via MHC class II and subsequent CD4
+ T cell activation, which in
turn boosts antibody production by the infected B cell.
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e13016Antibody transfer studies have shown that the requirement for B
cells in the clearance of Salmonella does not solely depend on
antibody formation [21]. Which additional immune responses
need B cell involvement remains unclear. For clearance of
Salmonella, not only the humoral immune response is required,
but also the activation of cytotoxic CD8
+ T cells is needed to
eliminate Salmonella-infected cells. Recently, DCs have been shown
to activate Salmonella-specific CD8
+ memory T cells after direct
uptake of bacteria or via suicide cross-presentation after uptake of
S. typhi-infected human cells [22]. As the generation of Salmonella
antigens for MHC class II molecules is an efficient process in
infected B cells, we tested whether BCR-mediated phagocytosis
also leads to cross-presentation of Salmonella antigens via the MHC
class I pathway of B cells and whether this elicits a cytotoxic T cell
response against Salmonella-infected cells.
Here we show that Salmonella-specific primary B cells that have
internalized Salmonella do cross-present Salmonella antigens via
MHC class I in a proteasome-dependent manner. Cross-
presentation of Salmonella antigens by B cells reactivates Salmonel-
la-specific CD8
+ memory cells that acquire a cytotoxic phenotype
and are efficient in killing of Salmonella-infected cells. Thus,
antigen-specific B cells are an under appreciated type of cell for the
induction of a cytotoxic T cell response against facultative
intracellular bacteria.
Results
Salmonella-infected B Cells Initiate a CD8
+ T Cell
Response
To study MHC class I antigen presentation by B cells, we used
Salmonella typhimurium as a model for cross-presentation against
facultative intracellular bacteria. Previously, we showed that about
4% of the B cells recognize Salmonella by their BCR, phagocytose
Salmonella, and subsequently initiate a CD4
+ T cell response [20].
Now, we investigated whether Salmonella-infected B cells are also
capable to induce a cytotoxic CD8
+ T cell response. B cells were
incubated with Salmonella to allow phagocytosis of the bacteria by B
cells. After extensive washing,the Salmonella-infectedB cells were co-
cultured with CFSE-labeled CD4
+ and CD8
+ T cells. As observed
before, B cells that had phagocytosed Salmonella induced CD4
+ T
cellproliferation [20]. Interestingly,a considerable amountof CD8
+
T cells had proliferated as well (Fig. 1A and B). Since the amount of
B cells that specifically recognize Salmonella via the BCR is quite low,
we maximized the T cells responses by enhancing the uptake of
Salmonella by B cells using Salmonella coated with a tetrameric
antibody complex, consisting of anti-LPS antibodies and anti-IgM-
BCR antibodies. As a result, all B cells expressing an IgM-BCR,
recognize Salmonella and phagocytose the bacterium via their BCR.
This resulted in an uptake of Salmonella by 30% to 60% of the B cells
(data not shown) and a strong increase in CD8
+ T cell proliferation
in B/T co-culture experiments. Next, we investigated the
requirement of CD4
+ T cell help for the proliferation of the
CD8
+ T cells. Salmonella-infected B cells were cultured with CD8
+ T
cells in the absence of CD4
+ T cells. This situation almost
completely abolished proliferation of the CD8
+ T cells with both
naturally phagocytosed Salmonella-infected B cells or coated
Salmonella-infected B cells (Fig. 1C and D). Thus, B cells infected
by Salmonella act as antigen presenting cells and induce CD8
+ T cell
proliferation, but activation of CD8
+ T cells requires the
simultaneous CD4
+ T cell activation to enable T cell help. To
study which kind of help CD4
+ T cells provide for CD8
+ T cell
proliferation, we looked at the requirement of IL-2, by adding
blocking antibodies to the culture of infected B cells and CD4
+ and
CD8
+ T cells. This resulted in a very strong reduction of CD8
+ T
cell proliferation (Fig. S1). However, CD4
+ T cell proliferation was
also decreased (data not shown). Therefore we performed a
converse experiment, by adding IL-2 instead of CD4
+ cells to the
co-culture of infected B cells and CD8
+ T cells. This shows that
substitution of CD4
+ T cell help by IL-2 also induces CD8
+ T cell
proliferation by B cells that have phagocytosed Salmonella (Fig. 1E).
The addition of IL-2 to the co-culture with non-infected B cells did
not induce significant proliferation of CD8
+ T cells, indicating that
IL-2 itself does not stimulate non-specific CD8
+ T cell proliferation.
Furthermore, the role of CD40 stimulation was studied. Since
CD40-CD40L interactions do also play a role in CD4
+ T cell
activation, CD4
+ T cell help was substituted by IL-2. Blocking
CD40 resulted in reduction of CD8
+ T cell proliferation (Fig. 2E).
Thus CD4
+ T cells help is partially mediated by both IL-2 and
CD40-CD40L interactions.
Although CD8
+ T cells proliferate only in presence Salmonella-
infected B cells and CD4
+ T cell help, we cannot exclude that the
CD8
+ T cell response is partly an effect of bystander proliferation,
for instance via soluble factors. Therefore, we studied the T cell
response in more detail. Culture supernatant of infected B cells in
presence of CD4
+ T cell help was not able to induce CD8
+ T cell
proliferation (data not shown). In addition, blocking experiments,
in which CD8
+ T cell activation was prevented via anti-CD8
blocking antibodies, resulted in a decrease of CD8
+ T cell
activation by Salmonella-infected B cells (Fig. S1). To study
Salmonella-specific T cell proliferation in more detail, restimulation
of the T cells was studied. Proliferating CD8
+ T cells which
respond to Salmonella-infected B cells were sorted. These Salmonella-
responsive T cells were restimulated with autologous B cells which
were infected with Salmonella, or anti-IgM coated Salmonella to
maximize the infection rate. During restimulation additional IL-2
was added for help, and CD8
+ T cell proliferation was measured
using CFSE labeling. This showed that CD8
+ T cells are primary
Salmonella-specific, because they proliferate mainly upon restimu-
lation with Salmonella-infected B cells (Fig. 1F). In addition, we
analyzed clonality of the Salmonella-specific T cell response using a
TCR beta clonality assay, as an additional indication for antigen-
specific T cell activation. Proliferating CD8
+ T cells, which were
activated by Salmonella-infected B cells, and non-proliferating
CD8
+ T cells, which did not respond, were both sorted and tested
for clonal TCR beta gene rearrangements. Subsequently, CD8
+ T
cells were stimulated with anti-CD3 and anti-CD28 antibodies to
obtain non-specific proliferated T cells. The CD8
+ T cells which
proliferate upon Salmonella-infected B cells show a clear clonality
(Fig. 1G). In contrast, neither CD8
+ T cells did proliferate after
culturing with infected B cells, nor non-specific CD8
+ T cells
proliferating cells show a clear TCR clonality. Thus, primary B
cells which have phagocytosed Salmonella elicit CD8
+ T cell
proliferation, which is mainly Salmonella-specific.
Salmonella-infected B Cells Activate Both the Central
Memory and Effector Memory CD8
+ Compartment
Do B cells elicit a naı ¨ve or a memory CD8
+cell response? To study
this, we cultured the total CD8
+ T cell population with or without
Salmonella-infected B cells, in presence of CD4
+ T cells for help, and
determined the naı ¨ve (CD45RO
2CD27
+;T N), central memory
(CD45RO
+CD27
+;T CM), effector memory (CD45RO
+CD27
2;
TEM) or terminal effector (CD45RO
2CD27
2;T E)p h e n o t y p eo f
the CD8
+ T cells after prolonged culture. Upon 11 days of culture,
purified CD8
+ T cells show mainly a naı ¨ve phenotype. In contrast,
following activation with Salmonella-infected B cells, the CD8
+
population shifts towards the TEM phenotype (Fig. 2A). CD8
+ T
cellsthatareactivatedwithSalmonella-infectedBcellsintheabsenceof
CD4
+ T help, do not differentiate to a TEM phenotype (Fig. 2B).
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cells at all. Therefore we studied proliferation of sorted naı ¨ve
(CD45RA
+CD45RO
2;T N) or memory (CD45RA
2CD45RO
+;
TMEM)C D 8
+ Tc e l l si nr e s p o n s et oSalmonella-infected B cells.
Figure 2C illustrates that the naı ¨ve CD8
+ population do not
proliferate over background values upon stimulation with Salmonel-
la-infected B cells, whereas the memory CD8
+ T cells proliferated
vigorously. Further discrimination of the memory subset by sorting
Figure 1. Salmonella-infected B cells induce CD8
+ T cell proliferation with help of CD4
+ T cells. (A) CFSE labeled CD8
+ T cells were cultured
alone (T), together with B cells (B + T) or together with B cells that had naturally phagocytosed Salmonella (BSal* + T), in the presence of CD4
+ T cells.
Proliferation was measured after 6 days. (B) CD8
+ T cell proliferation was measured after culture with B cells that had naturally phagocytosed
Salmonella (BSal*) or anti-IgM-coated Salmonella (BSal), in presence of CD4
+ T cell help. The data are expressed as mean 6 SEM, of seven independent
experiments of different donors. (C) Proliferation of CFSE labeled CD8
+ T cells (shown in A) in absence of CD4
+ T cells. (D) CD8
+ proliferation after
culture with B cells that have naturally phagocytosed (BSal*) or coated (BSal) Salmonella, in the presence of CD4
+ T cell help (black bars) or not (open
bars). The data are expressed as mean 6 SEM, of four independent experiments of different donors. (E) CD8
+ T cells were cultured with B cells that
had phagocytosed anti-IgM coated Salmonella (BSal), in absence of help (open bars), in presence of CD4
+ T cell help (black bars), in addition of IL-2
(striped bars), or in addition of IL-2 plus anti-CD40 antibodies. Data shown are from one representative experiment of three independent experiments
with different donors. (F) CD8
+ T cells were primed with B cells that had naturally phagocytosed Salmonella and the proliferating CD8
+ T cells were
sorted after 6 days, expanded with IL-2. Resting CD8
+ T cells were again CFSE labeled at day 13 and restimulated with autologous B cells or B cells
that had phagocytosed Salmonella naturally (BSal*) or coated Salmonella (BSal), in presence of IL-2 (50 IU/ml). The data are expressed as mean 6 SEM,
of two independent experiments of different donors. (G) CD8
+ T cells were activated with B cells that had naturally phagocytosed Salmonella, or non-
specific via anti-CD3 and anti-CD28 antibodies. CD8
+ T cells were sorted after 6 days and TCR clonality was measured. Shown are two different V-J
primer mixes, with a positive control (+), negative control (2), sorted proliferating CD8
+ T cells upon infected B cells (Sal
+), sorted non-proliferating
CD8
+ T cells upon infected B cells (Sal
2) and non-specific stimulated CD8
+ T cells (3/28). Data are of one experiment.
doi:10.1371/journal.pone.0013016.g001
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+ memory response. (A) CD4
+ and CD8
+ T cells were cultured alone (T), together with B
cells (B + T) or with anti-IgM-coated Salmonella-infected B cells (BSal + T). After 11 days, cells were stained for CD45RO and CD27 to discriminate
between the different T cell populations: naı ¨ve (TN; CD45RA
+CD27
+), central memory (TCM; CD45RO
+CD27
+), effector memory (TEM; CD45RO
+CD27
2)
and terminal effector (TE; CD45RA
+CD27
2) T cells. Gated CD8
+ cells were analyzed. (B) Without CD4
+ T cells, the differentiation of CD8
+ T cells to
effector memory is attenuated. Data are mean 6 SEM from five independent experiments. (C) Coated Salmonella-infected B cells activate proliferation
of sorted CD8
+CD45RO
+ cells (TMEM), but not of purified CD8
+CD45RA
+ cells (TN) in the presence of CD4
+ help. Data are mean 6 SEM from four
independent experiments. (D) Coated Salmonella-infected B cells activate proliferation of sorted CD8
+CD45RO
+CD27
+ (TCM) and CD8
+CD45RO
+CD27
2
(TEM) cells. Data are mean 6 SEM from three independent experiments. (E) Sorted CD8
+CD45RA
+ (naı ¨ve, TN) or CD8
+CD45RO
+ (memory, TMEM) T cells
were cocultured with B cells or DCs, naturally infected with Salmonella (Sal*), in presence of CD4
+ T cell help. Proliferation of the naı ¨ve or memory
CD8
+ T cells was measured at day 6. Data shown are from one representative experiment of two independent experiments with different donors. (F)
Sorted naı ¨ve or memory CD8
+ T cells were cocultured with B cells or DCs, infected with coated Salmonella (Sal), in presence of CD4
+ T cell help.
Proliferation of the naı ¨ve or memory CD8
+ T cells was measured at day 6. Data shown are from one representative experiment of two independent
experiments with different donors.
doi:10.1371/journal.pone.0013016.g002
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+CD27
+)a n dT EM (CD45RO
+CD27
2)C D 8
+ T
cells, followed by co-culture with Salmonella-infected B cells, showed
that both TCM and TEM can be activated by Salmonella-infected B
cells, although that TEM proliferate less compared to TCM (Fig. 2D).
Recent experiments in mice show that both TCM and TEM cells can
arise from activation and proliferation of the TCM compartment,
whereas TEM cells are more terminally differentiated and therefore
proliferate poorly and only give rise to TEM progeny [23]. Indeed,
expansion of the sorted TCM by Salmonella-infected B cells yielded
offspring with both a TCM and a TEM phenotype, whereas TEM
activation yielded mainly TEM progeny (data not shown). In addition,
the effectiveness of T cell activation by infected B cells was compared
using another antigen presenting cell, a dendritic cell (DC). After
uptake of Salmonella, the DCs matured (data not shown) and were
capable to activate both naı ¨ve (TN) and memory CD8
+ Tc e l l s
(TMEM), whereas B cells could only reactivate memory CD8
+ Tc e l l s
(Fig. 2E). However, the percentage of B cells that had taken up
Salmonella was much lower compared to the DCs that had taken up
Salmonella (Fig. S2). To correct for these differences in uptake, we also
used anti-IgM coated Salmonella, to enhance the number of Salmonella-
infected B cells. Indeed this yielded comparable amounts of
Salmonella-infected B cells and DCs (Fig. S2). In this setting,
Salmonella-infected B cells were even superior in activation of memory
CD8
+ cells (Fig. 2F). So, upon Salmonella-infection, B cells can reactive
CD8
+ memory cells in the same manner as DCs. In summary, these
data show that Salmonella-infected B cells activate an effective recall
response of memory CD8
+ T cells, yielding expansion of both the
‘‘memory stem cell’’ containing TCM compartment and the memory
effector cell containing TEM compartments.
Activated Salmonella-specific CTLs are Able to Kill
Salmonella-infected Cells
Activation of cytotoxic CD8
+ T cells by B cells is controversial.
Earlier reports showed that B cells induce tolerance or anergy in
CD8
+ T cells. In contrast, we showed proliferation of CD8
+ T cells
upon activation by antigen-specific B cell upon phagocytosis of
Salmonella. Although this proliferation is unlikely to yield tolerance,
proliferation itself does not guarantee that the activated CD8
+ T
cells have acquired a functional anti-bacterial phenotype. CD8
+ T
cells kill intracellular pathogens either via secretion of IFN-c or via
direct killing of the infected target cell [24]. To investigate if
Salmonella-containing B cells induce a functional CD8
+ T cell
response, IFN-c secretion of the activated CD8
+ T cells was
measured. This showed that, after culture with Salmonella-infected
B cells, the number of CD8
+ T cells producing IFN-c is increased
to more than 65% (Fig. 3A and 3B). Thus, cross-presentation of
Salmonella antigens by B cells induces not only proliferation of the
CD8
+ T cells but also renders the cells functional in that it induces
IFN-c secretion.
As these data demonstrate that B cells that had taken up
Salmonella are able to functionally activate CD8
+ T cells, the
question remained if the activated CD8
+ T cells were Salmonella-
Figure 3. Salmonella-infected B cells induce Salmonella-specific CD8
+ T cells to secrete IFN-c and are cytotoxic. (A) CD4
+ and CD8
+ T cells
were cultured alone (T), with B cells (B + T) or with anti-IgM-coated Salmonella-infected B cells (BSal + T). After 11 days, CD8
+ T cells were stimulated for
5 hours with PMA, ionomycin and BFA and analyzed for IFN-c production by intracellular FACS staining. A representative experiment of five
independent experiments using cells from different healthy donors is shown. (B) Salmonella-infected B cells induce IFN-c-expression by CD8
+ T cells
compared to non-infected B cells. Data are the mean 6 SEM from five independent experiments of different donors and ** p,0.01. (C) CD8
+ T cells
were primed with coated Salmonella-infected B cells and the proliferating CD8
+ T cells were sorted after 6 days, expanded with IL-2 for another 6 days
and restimulated with autologous B cells that had either or not phagocytosed Salmonella. Salmonella-specific degranulation was measured by
CD107a expression at the plasma membrane CD8
+ T cells. Data are means 6 SEM of five independent experiments of different donors, and **
p,0.01. (D) Proliferating CD8
+ T cells primed with B cells that had naturally phagocytosed Salmonella were sorted and CD107a expression was
measured upon re-encounter of B cells (T + B), B cells naturally infected with Salmonella (T + BSal*) or anti-IgM-coated Salmonella (T + BSal). Data are of
two experiments. (E) Sorted Salmonella-primed CD8
+ T cells (see C) specifically kill Salmonella-infected B cells as measured by
51Cr release of
autologous B cells that were either or not infected with Salmonella. Data are expressed as mean 6 SEM, of six independent experiments of different
donors, and ** p,0.01. (F) Sorted Salmonella-primed CD8
+ T cells (see C) do not kill Staphylococci-infected B cells as measured by
51Cr release of
autologous B cells that were either infected with Salmonella or with Staphylococci. The data are expressed as mean 6 SEM, of two independent
experiments of different donors.
doi:10.1371/journal.pone.0013016.g003
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+ T cells can acquire a cytotoxic
phenotype through B cell-mediated activation. First, we investi-
gated if the CD8
+ T cells degranulate their cytotoxic granules
upon recognition of Salmonella-infected target cells. For this we
analyzed expression of the marker CD107a, which is expressed at
the plasma membrane of CD8
+ T cells upon degranulation.
Salmonella-infected B cells were cultured together with CFSE
labeled CD4
+ and CD8
+ T cells. The proliferating Salmonella-
primed CD8
+ T cells were sorted after 6 days, expanded and re-
exposed to autologous B cells that had been infected to high
percentages with anti-IgM-coated Salmonella after which CD107a
expression was measured. Upon re-exposure to Salmonella-infected
B cells, the Salmonella-primed CD8
+ T cells show a strong and
significant increase of CD107a expression at the plasma
membrane. Since the proliferating CD8
+ T cells did not show
degranulation when re-exposed to autologous, non-infected B
cells, Salmonella-primed CD8
+ T cells degranulate specifically upon
recognition of Salmonella-infected cells (Fig. 3C). To exclude the
possibility that the anti-IgM coating of Salmonella had affected our
results, we also primed CD8
+ T cells with Salmonella-specific B cells
that had naturally phagocytosed Salmonella via their antigen-
specific BCR. These primed CD8
+ T cells degranulated
specifically upon recognition of autologous B cells naturally
infected with Salmonella, of which a relative small percentage (5–
10%, data not shown) contained Salmonella-infected antigen-
specific B cells (Fig. 3D; middle bar). In addition, the naturally
Salmonella-primed CD8
+ T cells very efficiently degranulated upon
contact with autologous B cells of which a higher percentage (26–
46%, data not shown) of cells had been infected with anti-IgM
coated Salmonella (Fig. 3D; right bar). Finally, we investigated if
degranulation of the Salmonella-specific CD8
+ T cells also leads to
death of the Salmonella-infected cells to determine the true cytotoxic
efficacy of the lytic granules. CFSE labeled CD8
+ T cells were
primed by incubation with Salmonella-infected B cells. Proliferating
CD8
+CFSE
low cells were sorted and expanded for another 6 days.
Re-exposure of the Salmonella-primed T cells to Salmonella-infected,
51Cr-labeled autologous B cells demonstrated that the primed
CD8
+ T cells killed Salmonella-infected B cells but not non-infected
B cells (Fig. 3E). In addition, the Salmonella-primed CD8
+ T cells
were not able to kill B cells that had phagocytosed Staphyloccoci via
BCR ligation (Fig. 3F), demonstrating that the CD8
+ cells are
indeed at least partly Salmonella-specific and do not recognize
autologous B cells that are activated via BCR-mediated uptake of
other bacteria. Thus, activation of CD8
+ T cells by B cells cross-
presenting Salmonella antigens induces a cytotoxic phenotype in the
CD8
+ T cells that specifically mediates killing of Salmonella-infected
cells.
Cross-Presentation of Salmonella-antigens is Partly
Proteasome Dependent
We showed that after phagocytosis of Salmonella, B cells are able
to cross-present antigens to CD8
+ T cells and thereby initiate a
Salmonella-specific cytotoxic T cell response. The mechanism of
cross-presentation of Salmonella antigens by B cells is unknown.
One likely mechanism is that after phagocytosis, antigens are
translocated from the Salmonella-containing vacuole (SCV) into the
cytoplasm of B cells. Next, the antigens are degraded in the
cytoplasm by proteasomes into small peptides, which are presented
via the classical MHC class I antigen presentation route. To
investigate this mechanism of cross-presentation, we used a
chemical compound that specifically blocks the proteasome
(MG-132). To study the effect of cross-presentation when blocking
the proteasome, we used the CD107a degranulation assay. Re-
exposure of Salmonella-primed CD8
+ T cell to autologous,
Salmonella-infected B cells showed that Salmonella-infected B cells
are much less efficient in inducing CD8
+ T cell degranulation
when proteasomes are inhibited (Fig. 4). In addition, proteasome
inhibition of the infected B cells also prevents killing by Salmonella-
specific CD8
+ T cells (data not shown). This observation implies
that the proteasome is somehow involved in cross-presentation of
Salmonella antigens by B cells. How the proteasome is involved is
unclear as proteasome inhibition has many secondary effects on
the ubiquitin cycle, the modification of histones and the formation
of multivesicular bodies [25].
B Cells do not Cross-Present Heat-killed Salmonella
Salmonella survives inside a cell via expression of the TTSS that
create an intracellular environment that neutralizes the destructive
forces of the host cell [26]. The TTSS components SPI-1 and SPI-
2 play a role in this process by exporting proteins into the host cell.
Because of the capacity of Salmonella to invade cells and to control
its maintenance inside the cell via SPI-1 and SPI-2, it is possible
that Salmonella itself might play a direct role in the cross-
presentation pathway in B cells. To determine the role of SPI-1
and SPI-2 in cross-presentation of Salmonella by B cells, we
analyzed CD8
+ T cells proliferation via co-culture with CD4
+ T
cells and B cells that had phagocytosed anti-IgM-coated wild type
Salmonella,o rSalmonella with a mutation in SPI-1 (invA
2) or SPI-2
(ssrA
2). Both Salmonella mutants were still able to elicit a CD8
+ T
cell response, albeit at lower percentages of T cell proliferation
compared to wild type Salmonella (Fig. 5A). Thus SPI-1 and SPI-2
each contribute to cross-presentation of Salmonella antigens by B
cells, but are not essential.
By creating an environment in which Salmonella itself cannot be
killed, it is possible that the intracellular survival plays a role in the
efficacy of cross-presentation of Salmonella antigens by B cells. To
Figure 4. Proteasome inhibition of Salmonella-infected B cells
diminishes degranulation of Salmonella-specific CD8
+ T cells.
CD8
+ T cells were activated by Salmonella-infected B cells and after 6
days, Salmonella-specific, proliferating CD8
+ T cells were sorted. Next,
the sorted CD8+ T cells were reactivated by non-infected B cells (T + B)
or Salmonella-infected B cells (T + BSal). Pre-treatment of B cells with
proteasome inhibitor MG-132 (20 mM) before reactivation leads to a
decrease in degranulation of the Salmonella-specific CD8
+ T cells (T +
B[MG-132]Sal), as measured by CD107a expression. The data are
expressed as mean 6 SEM, of two independent experiments of
different donors.
doi:10.1371/journal.pone.0013016.g004
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presentation of Salmonella antigens, we compared the efficiency of
living and dead Salmonella to induce CTL activation. CD8
+ T cells
were primed with B cells infected with living or heat-killed
Salmonella. After sorting and expansion, the Salmonella-primed T
cells were re-exposed to autologous B cells that had either or not
phagocytosed living or dead Salmonella. Cross-presentation of
Salmonella antigen was measured by the extent of degranulation of
the primed T cells using CD107a expression. CD8
+ T cells that
had been primed by B cells infected with living Salmonella
efficiently degranulated upon recognition of autologous B cells
that had phagocytosed living Salmonella (upregulation of CD107a
to 60%), whereas the cells did not degranulate upon contact with B
cells that had phagocytosed dead Salmonella (Fig. 5B; left panel).
This indicates either that B cells present different Salmonella
antigens to CD8
+ T cells from live or dead bacteria or that B cells
cannot cross-present Salmonella antigens when the intracellular
bacterium is not alive. Furthermore, CD8
+ T cells that had been
primed with B cells that had taken up dead Salmonella showed poor
degranulation to B cells that had taken up either live or heat-killed
Salmonella (Fig. 5B; right panel), demonstrating that B cells indeed
do not induce a cytotoxic CD8
+ T cell response via cross-
presentation of Salmonella antigens from dead intracellular bacteria.
This observation was confirmed by studying elimination of
Salmonella-infected B cells by
51Cr-release (Fig. 5C). Together,
these results show that B cells are not able to cross-present antigens
of dead Salmonella and that Salmonella contributes to the activation
of a Salmonella-specific cytotoxic CD8
+ memory response.
Discussion
Studies in B-cell-deficient mice showed that protective immu-
nity to Salmonella strongly depends on B cells [27]. This
dependency does not only result from antibody generation, as
passive transfer of Salmonella-immune serum cannot transfer
resistance to Salmonella [28]. In addition, B cells are involved in
the generation of a profound CD4
+ and CD8
+ T cell response
after Salmonella infection [21], but the precise role of B cells
remained unclear. We previously showed that human antigen-
specific B cells that have internalized Salmonella via their BCR are
able to induce a Salmonella-specific CD4
+ T cell response which
aids the humoral immune response against Salmonella [20]. The
data described here may explain the role of B cells in the immune
response against Salmonella infection other than antibody forma-
tion. In contrast to data in mouse B cell lines, in which uptake of
Salmonella does not lead to antigen cross-presentation via MHC
class I [29], we now demonstrate that Salmonella-specific human
primary B cells that have phagocytosed Salmonella via their BCR
are capable to induce a strong recall response of cytotoxic CD8
+ T
cells after cross-presentation of Salmonella antigens. We previously
showed that in the human Ramos B cell line, Salmonella is not only
capable to survive, but also to replicate intracellularly. In contrast,
in primary human B cells Salmonella survives, but is unable to
replicate inside the B cell [20]. A recent report shows that poor
intracellular replication of Salmonella leads to reduced antigen
presentation in DCs [30]. In contrast, we found that Salmonella-
specific primary B cells are efficient in cross-presentation of
Salmonella antigens from the non-replicating bacteria and activate
Salmonella-specific CD8
+ cells that show a functional cytotoxic T
cell response. Thus, primary human B cells are capable in cross-
presentation of non-replicating Salmonella to CD8
+ T cells.
After internalization by the B cell, Salmonella survives in the
SCV. For cross-presentation, Salmonella-antigens should be loaded
onto MHC class I. The TTSS of Salmonella could play a role in
delivery of antigens in the cytosol by injecting proteins directly into
the cytosol [31]. These proteins can be degraded by the
proteasome and after transportation into the ER, loaded onto
MHC class I molecules. We demonstrated that both SPI-1 and
SPI-2 contribute to cross-presentation, but are not individually
required. It is therefore likely that antigens excreted in the host
cytosol by SPI-1 and SPI-2 are both used for antigen processing to
MHC class I. This is in line with the observation that B cells could
not cross-present Salmonella-specific antigens of heat-killed Salmo-
nella in which SPI-1 or SPI-2 are no longer active. Although the
exact molecular pathways of cross-presentation in B cells remain
to be elucidated, it is clear that Salmonella itself appears to be
involved in the generation of an effective cytotoxic CD8
+ T cell
response against the bacteria upon B cell infection. This
phenomenon points to the occurrence of co-evolution of bacterial
immune evasion and the generation of effective anti-bacterial
immunity.
Cross-presentation of Salmonella antigens by B cells leads to
activation of a CD8
+ cytotoxic T cell response, but help of CD4
+ T
cells is required. The main factor of CD4
+ T cell help seems to be
Figure 5. Induction of CTL response against Salmonella by B cells requires uptake of living Salmonella. (A) CD8
+ T cells were labeled with
CFSE and cultured with B cells that had phagocytosed either wild type Salmonella (WT), mutant for SPI-1 (invA
2) or SPI-2 (ssrA
2). Proliferation was
measuredafter6days.DatashownareproliferationofCD8
+cellsrelativetowildtypeproliferationandareoftwodifferent donors;errorbars areSEM.(B)
Salmonella-specific T cells that were primed with B cells that had either internalized living (left panel) or dead Salmonella (right panel) were sorted and
restimulated with B cells (T + B), B cells that had internalized living Salmonella (T + BSal)o rd e a dSalmonella (T + BSal-hk). Degranulation was analyzed as
CD107a expression by CD8
+ T cells. (C)CD8
+ T cell mediated kill was measured as the release of
51Cr by B cells. (B–C) Data areexpressed as mean 6 SEM,
from four (live Salmonella primed) or two (dead Salmonella primed) independent experiments using material from different healthy donors.
doi:10.1371/journal.pone.0013016.g005
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+ T cell help by addition of IL-2 is
sufficient to elicit CD8
+ T cell proliferation, induced by Salmonella
infection of the B cells. The CD4
+ dependency of the CD8
+
response led us to investigate if the observed responses were in fact
mere bystander activation. Proliferation upon restimulation of
Salmonella-primed CD8
+ T cells implies Salmonella-specificity of
CD8
+ T cell activation. In addition, the observations that CD8
+ T
cells activated by Salmonella-infected B cells specifically kill
Salmonella-infected cells, but do not kill B cells infected with
Staphylococci or dead Salmonella, demonstrate that the CD8
+ T cell
response upon Salmonella-infection of autologous B cells is at least
in part Salmonella-specific.
Various reports have described that B cells play a role in the
expansion of Salmonella-specific T cells during reinfection, but less
in the induction of CD8
+ T cell responses in primary infection.
The reason for this was not understood and has been attributed to
the fact that antigen-specific B cells are probably the main B cell
population with an antigen presenting function in Salmonella
infection and that the frequency of antigen-specific B cells is
elevated during a secondary infection (reviewed in [32]). Our data
now show that indeed the antigen-specific B cells are the cells that
are responsible for efficient cross-presentation of Salmonella
antigens. In addition, our data provide an additional explanation
why B cells are mainly involved in the recall response; Salmonella-
infected B cells do not prime naı ¨ve CD8
+ T cells, but are very
efficient in reactivation of cytotoxic CD8
+ memory T cells. This
implies that other APCs (e.g. DCs) are still needed to prime naı ¨ve
CD8
+ T cells. This priming by DCs might occur via antigen-
presentation after phagocytosis of Salmonella itself, or via uptake of
apoptotic bodies from other Salmonella-infected DCs. In secondary
infections however B cells now seem to enter the stage as
important APCs for the execution of the CD8
+ recall response.
DCs can still induce CD8
+ proliferation via direct infection or via
suicide cross-presentation upon ingestion of infected apoptotic cells
[22], but DCs were shown to mainly activate the TEM
compartment [22]. In contrast, Salmonella-infected B cells efficient-
ly activate the both the TCM and TEM compartments. This ensures
not only the direct terminal differentiation of effector memory
cells, but also the expansion of the Salmonella-specific CD8
+
memory T cell compartment, which may both amplify the anti-
Salmonella immune response and simultaneously ensure generation
of anti-Salmonella memory for further reinfections.
In summary, we propose a model on the role of B cells in the
generation of the humoral and cellular immune response against
Salmonella. After infection, Salmonella enters the body via DCs. The
DC-mediated route ensures CD4
+ T cell activation but is less
effective in CD8
+ T cell activation [30]. The other part of entry for
Salmonella is via M cells after which it encounters B cells, which are
situated in the Peyer’s Patches, directly under the M cells.
Salmonella-specific B cells internalize Salmonella via their BCR and
are activated. Next, internalization of Salmonella leads to presen-
tation of Salmonella antigens MHC class II molecules and activation
of Salmonella-specific CD4
+ T-helper cells that stimulate Salmonella-
infected B cells to secrete Salmonella-specific antibodies [20], either
locally or upon arrival or the infected B cells in the mesenteric
lymph node. Upon re-infection, Salmonella-specific memory B cells
ensure rapid antibody production but Salmonella-infected B cells
also mediate a strong cytotoxic CD8
+ recall response to eliminate
infected cells. The Salmonella-specific CD4
+ response that aided
antibody production in early stages of the immune response is now
also required for the activation of the cytotoxic memory T cell
response against Salmonella. Thus, uptake of Salmonella by antigen-
specific B cells may generate a survival niche for Salmonella, but at
the same time it strongly contributes to the generation of effective
anti-Salmonella immunity at multiple levels of the adaptive immune
response.
Materials and Methods
Antibodies and fluorophores
mAb anti-human IgM (MH15, Sanquin, Amsterdam, The
Netherlands) was mixed with rat anti-mouse IgG1 antibody
(RM161.1, Sanquin) and mAb anti-S. typhimurium LPS (1E6,
Biodesign International, Kennebunk, ME) to generate BCR-LPS
tetrameric antibody complexes, used to coat bacteria as previously
described [20]. Antagonist anti-human CD40 mouse monoclonal
antibody was a kind gift of Dr. L. Boon.
The following labeled anti-human mAbs were obtained from
BD Biosciences (San Jose, CA): anti-IFN-c-FITC, anti-CD27-PE,
anti-CD107a-PE, anti-CD8-PerCP-Cy5.5, anti-CD4-APC, anti-
CD45RO-PE, AnnexinV-APC and IgG1-PerCP-Cy5.5 isotype
control. FITC-conjugated antibody IgG1, IgG2a and IgG2b,
IgG1-PE and IgG1-APC isotype controls and PE-conjugated anti-
CD8 blocking antibody were obtained from DAKO (Glostrup,
Denmark). Anti-CD45RA-FITC and anti-CD45RO-FITC were
obtained from Sanquin and DAPI from Sigma-Aldrich (Stein-
heim, Germany). CFSE (Invitrogen, Paisley, UK) labeling was
used in proliferation assays.
Bacterial growth conditions
GFP expressing-S. typhimurium SL1344 was described before
[33]. GFP-Salmonella defective in SPI-1 (invA mutant) or SPI-2
(ssrA mutant) were a kind gift of M. Rescigno (European Institute
of Oncology, Milan, Italy). Staphylococcus aureus expressing GFP
(RN4220 with pWVW189GFP) was kindly provided by S. A. J.
Zaat (Academic Medical Center, Amsterdam, The Netherlands).
All bacteria strains were grown overnight at 37uC in Luria-Bertani
(LB) broth with carbenicillin or chloramphenicol (Sigma-Aldrich,
St Louis, MO) to maintain GFP expression while shaking,
subcultured at a dilution of 1:33 in fresh LB medium and
incubated while shaking at 37uC for 3 to 4 hours to obtain
exponentially growing bacteria. For coating, bacteria were washed
twice with PBS and incubated with BCR-LPS tetrameric antibody
complexes for 30 minutes at room temperature and washed twice
with PBS to remove unbound antibodies. For experiments with
dead Salmonella, bacteria were heat killed by incubation at 65uC for
15 minutes.
Lymphocyte isolation and B lymphocyte infection with
Salmonella
Human PBMCs were isolated by centrifugation on a Ficoll-
Hypaque gradient (Axis-Shield PoC AS, Oslo, Norway) from a
buffycoat obtained from healthy donors (Sanquin). All donors
provided written informed consent in accordance with the
protocol of the local institutional review board, the Medical Ethics
Committee of Sanquin Bloodbank (Amsterdam, The Netherlands),
and the Medical Ethics Committee of Sanquin approved the
study. B and T cells were subsequently purified using anti-CD19,
anti-CD4, anti-CD8 Dynabeads and DETACHaBEAD (Invitro-
gen), according to the manufacturer’s instructions. Monocytes
were isolated by positive selection using CD14 microbeads and a
magnetic cell separator (MACS, Miltenyi Biotec, Bergisch
Gladbach, Germany). Monocytes were cultured at a concentration
of 1610
6 cells/ml in 20 ml Cellgro medium (CellGenix, Freiburg,
Germany) supplemented with GM-CSF (1,000 IU/ml; Cellgenix)
and IL-4 (800 IU/ml; Cellgenix) in a 80 cm
2 cell culture flask
(Nunc, Roskilde Denmark) to generate immature DCs. At day 6,
the DCs were harvested and washed with antibiotic free medium.
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37uC with Salmonella without antibiotics. Next, cells were washed
to remove unbound bacteria four times and cultured for 1 hour in
medium containing 100 mg/ml gentamycin (Invitrogen) to elim-
inate non-phagocytosed bacteria. Cells were washed and cultured
in RPMI 1640 medium w/o phenol red (Lonza, Basel, Switser-
land), supplemented with 5% FCS (Bodinco, Alkmaar, The
Netherlands), 100 U/ml penicillin, 100 mg/ml streptomycin,
2 mM L-Glutamine, 50 mM 2-ME, 20 mg/ml human apo-
transferrin ((Sigma-Aldrich), depleted for human IgG with protein
G sepharose (Amersham, Uppsala, Sweden)) and 10 mg/ml
gentamycin.
Flow cytometry
Unless described otherwise, 1*10
5 Salmonella-infected cells were
cultured with 5*10
4 CFSE-labeled T cells (CD8
+ T cells alone or
in 1:1 ratio with CD4
+ T cells) for 6 days to activate and expand
Salmonella-specific T cells. 50,000 events were acquired on a LSR
II (BD) and analyzed with FACSDiva software (BD). To test
plasma membrane markers, 1*10
5 B cells with 5*10
4 T cells were
cultured for 6 days and after addition of 10 IU/ml IL-2 (Chiron,
Emeryville) for another 6 days. All plasma membrane stainings
were performed for 15 minutes at room temperature and washed
after each incubation with PBS containing 0.1% BSA. 50,000
events were acquired on a LSR II (BD) and analyzed with
FACSDiva software (BD). Lymphocytes were gated by forward
and side scatter. Dead cells were excluded based on their positive
reaction to DAPI staining.
For some experiments, naı ¨ve T cells were sorted as CD8
+
CD45RA
+CD45RO
2 (TN) and memory T cells as CD8
+
CD45RA
2CD45RO
+ (TMEM), and CD8
+CD45RO
+CD27
2 (TEM)
and CD8
+CD45RO
+CD27
+ (TCM) cells. Populations were .98%
purified.
TCR clonality
CFSE labeled CD8
+ T cells were stimulated with Salmonella-
infected B cells or with anti-CD3 (1XE, 1 mg/ml) and anti-CD28
antibodies (CLB.CD28/1, 1 mg/ml). Proliferating and non-
proliferating cells were sorted and DNA was isolated using
QIAamp DNA Mini Kit, according to the manufacturer’s
instructions (Qiagen, Valencia, CA). Next, TCR beta clonality
was measured using the In Vivo Scribe TCRB Gene Clonality
Assay for gel detection, according to manufacturer’s instructions
(San Diego, CA).
Intracellular cytokine staining
B cells and T cells were cultured for 12 days, and 10 IU/ml IL-
2 was added at day 6 for T cell survival. Cytokine production was
measured by intracellular staining after restimulation with 0.1 mg/
ml PMA, 1 mg/ml ionomycin and 10 mg/ml brefeldin A (Sigma-
Aldrich) for 5 hours. Cells were washed twice with PBS, fixed with
1% formaldehyde (Merck, Darmstadt, Germany) for 15 minutes
and after washing twice with PBS, permeabilized with 0.5%
saponin (Calbiochem, CA) in PBS containing 1% BSA (Sigma-
Aldrich) and incubated with fluorescent antibodies for 30 minutes
at room temperature. 50,000 events were acquired on a LSR II
(BD) and analyzed with FACSDiva software (BD).
CD8
+ degranulation assay
CD8
+ T cells were primed by 6 day incubation of 1*10
5
Salmonella-infected B cells with 2.5*10
4 CD4
+ T cells and 2.5*10
4
CD8
+ T cells. The dividing T cells (CD8
+CFSE
low) were FACS
sorted after 6 days on a MoFlo Sorter (Dakocytomation, Glostrup,
Denmark) and cultured with 50 IU/ml IL-2 for 6 more days.
Next, isolated autologous B cells were thawed and infected with
Salmonella. For proteasome inhibition, MG-132 (Sigma-Aldrich)
was added at a concentration of 20 mM before incubation with
bacteria, and after infection, the cells were cultured overnight in
presence of the inhibitor. Next, the cells with proteasome inhibitor
were irradiated (30 Gy) to prevent further initiation of antigen
presentation after washing the cells to remove the proteasome
inhibitor. Cells were not irradiated in other experiments in which
no proteasome inhibitor was used. Salmonella-infected B cells were
incubated in medium containing 10 mg/ml gentamycin for
15 hours at 37uC to allow processing and presentation of Salmonella
antigens. Subsequently, the B cells were incubated at 37uC for
5 hours together with the primed Salmonella-specific CD8
+ T cells
in a ratio of 4:1, in the presence of anti-CD107a-PE labeled
antibodies. Cells were washed twice with wash buffer (1 mM
HEPES, 0.15 M NaCl, 5 mM KCl, 1.8 mM CaCl2, 1 M MgCl2,
0.1% BSA) and stained for CD8 and AnnexinV. After washing
twice with washing buffer, DAPI was added and CD8
+ T cells
were analyzed for CD107a expression. 50,000 events were
acquired on a LSR II (BD) and analyzed with FACSDiva software
(BD).
51Cr release assay
Salmonella-specific CD8
+ T cells were activated and FACS sorted
as described and expanded with 50 IU/ml IL-2. Autologous B
cells were thawed and infected with Salmonella. After 15h, B cells
were labeled with
51Cr (185 MBq/ml; Perkin Elmer, Boston, MA)
for 45 minutes at 37uC. After washing, the B cells were incubated
in a 96-wells U-bottom plate (Costar Corning Inc., NY) with
primed CD8
+ T cells in a 1:2 ratio. Incubation in medium or in
Triton X-100 (1% final concentration; Merck) was used to
determine spontaneous and maximum
51Cr release, respectively.
51Cr release was measured in the supernatant using filters with a
gamma counter (Cobra II, Canberra Packard, Mississauga,
Canada). The percentage of specific cell lysis was calculated using
the following formula:
% specific lysis = [experimental release (cpm) – spontaneous
release (cpm)]/[maximal release (cpm) – spontaneous release
(cpm)] 6100%.
Statistical analysis
Statistical differences were determined by a paired Student’s t
test, using GraphPad Prism (version 5.01, GraphPad Software,
San Diego, CA).
Supporting Information
Figure S1 Blocking IL-2 or blocking CD8 reduces Salmonella-
infected B cell mediated CD8
+ T cell proliferation. Salmonella-
infected B cells were cocultured with CFSE labeled CD8
+ T cells
and CD4
+ T cells, in presence of IL-2 blocking antibodies or CD8
blocking antibodies. CD8
+ T cell proliferation was measured after
6 days. Data shown are from one representative experiment of two
independent experiments with different donors.
Found at: doi:10.1371/journal.pone.0013016.s001 (1.38 MB TIF)
Figure S2 Uptake of Salmonella by B cells and DCs. B cells (upper
panel) or DCs (lower panel) were naturally infected with GFP
expressing Salmonella (Sal*, left) or infected with anti-IgM coated
Salmonella (Sal, right). Salmonella-GFP positive cells were analyzed 1
hour after infection. Data shown are from one representative
experiment of two independent experiments with different donors.
Found at: doi:10.1371/journal.pone.0013016.s002 (2.70 MB TIF)
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